edratide

Known as: hCDR1 peptide 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2007-2015
01220072015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
OBJECTIVE To evaluate the safety and efficacy of hCDR1 (Edratide) in patients with systemic lupus erythematosus (SLE). METHODS… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2009
2009
Systemic lupus erythematosus (SLE) is an autoimmune disorder characterized by dysregulation of cytokines, apoptosis, and B- and T… (More)
  • table 1
  • figure 2
  • figure 1
  • figure 3
  • figure 4
Is this relevant?
Review
2008
Review
2008
The success obtained with biologic therapies in rheumatoid arthritis and other inflammatory arthropathies has led to its use in… (More)
Is this relevant?
2008
2008
During the last decade, new biotherapies have been developed for the treatment of systemic autoimmune diseases, especially for… (More)
Is this relevant?
2007
2007
OBJECTIVE To identify genes that are differently expressed in (NZB x NZW)F(1) mice with established lupus compared with healthy… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2007
2007
Experimental systemic lupus erythematosus (SLE) can be induced in mice following immunization with an anti-DNA mAb expressing a… (More)
Is this relevant?